UK Markets open in 2 hrs 30 mins

CureVac N.V. (CVAC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.58+0.19 (+1.67%)
At close: 04:00PM EST
11.58 0.00 (0.00%)
After hours: 06:45PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.83
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 320.60
52-week low 35.63
50-day moving average 38.20
200-day moving average 311.44

Share statistics

Avg vol (3-month) 3944.09k
Avg vol (10-day) 31.4M
Shares outstanding 5187.05M
Implied shares outstanding 6N/A
Float 884.81M
% held by insiders 152.47%
% held by institutions 120.84%
Shares short (13 Oct 2022) 42.69M
Short ratio (13 Oct 2022) 47.81
Short % of float (13 Oct 2022) 43.72%
Short % of shares outstanding (13 Oct 2022) 41.44%
Shares short (prior month 14 Sept 2022) 43.46M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin -189.98%
Operating margin (ttm)-737.27%

Management effectiveness

Return on assets (ttm)-38.89%
Return on equity (ttm)-29.98%

Income statement

Revenue (ttm)115.08M
Revenue per share (ttm)0.62
Quarterly revenue growth (yoy)-10.00%
Gross profit (ttm)-135.09M
EBITDA -834.69M
Net income avi to common (ttm)-218.64M
Diluted EPS (ttm)-2.87
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)573.57M
Total cash per share (mrq)3.06
Total debt (mrq)40.21M
Total debt/equity (mrq)6.45
Current ratio (mrq)3.45
Book value per share (mrq)3.72

Cash flow statement

Operating cash flow (ttm)-659.4M
Levered free cash flow (ttm)-1.07B